Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer

International Journal of Biological Markers

Volumn 24, Issue 1, 2009, Pages 11-16

  Gangwar, Ruchika ^a   Mittal, Balraj ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Cytokine; Genetic susceptibility; Interleukin 6; Polymorphism

Indexed keywords

CYTOKINE; GUANINE; INTERLEUKIN 6;

ADULT; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHROMOSOME MAP; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN DENATURATION; SMOKING; SOCIOECONOMICS; UTERINE CERVIX CANCER;

NICOTIANA TABACUM;

EID: 67649989519     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.5370     Document Type: Article

References (21)

1. Munagala R, Nagarajan B. Alterations in cytokine levels in cervical carcinoma patients through radiation therapy. Current Science, 2008; 94: 1292-6.
2. Syrjänen KJ, Syrjänen SM. Papillomavirus infections in human pathology. Chichester, NY: John Wiley & Sons, Ltd, 2000.
3. Winkelstein W Jr. Smoking and cervical cancer - current status: a review. Am J Epidemiol 1990; l31: 945-58.
4. Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002; 46: 959-64.
5. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13: 357-68.
6. Schmauz R, Okong P, de Villiers EM, et al. Multiple infections in cases of cervical cancer from a high incidence area in tropical Africa. Int J Cancer 1989; 43: 805-9.
7. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41: 2502-12.
8. Castrilli G, Tatone D, Diodoro MG, Rosini S, Piantelli M, Musiani P. Interleukin 1 alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. Br J Cancer 1997; 75: 855-9.
9. Tjiong MY, van der Vange N, ten Kate FJ, et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer.Gynecol Oncol 1999; 73: 285-91.
10. Wei LH, Kuo ML, Chen CA, et al. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 2001; 82: 49-56.
11. Bowcock AM, Kidd JR, Lathrop GM, et al. The human interferon-beta 2 hepatocyte stimulating factor interleukin-6 gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988; 3: 8-16.
12. Shepherd JH. FIGO staging of gynecologic cancers; cervical and vulva. Int J Gynecol Cancer 1995; 5: 319.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
14. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88-8.
15. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127-37.
16. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
17. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease. Genes Immun 2001; 2: 61-70.
18. Nogueira de Souza NC, Brenna SM, Campos F, Syrjänen KJ, Baracat EC, Silva ID. Interleukin-6 polymorphisms and the risk of cervical cancer. Int J Gynecol Cancer 2006; 16: 1278-82.
19. Iacopetta B, Grieu F, Joseph D. The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br J Cancer 2004; 90: 419-22.
20. Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett 2004; 66: 326-31.
21. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980; 112: 564-9.